PATENT CLAIM ANALYSIS

Application Number: 16212582
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "279000"]

Abstract:
The present application provides a compound of formula (I) or a salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , A, G, M, Q and X are as defined herein. A compound of formula (I) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders.

Claim (Index 25):
The method according to  claim 12  wherein R 1 , R 2  and R 11  are H.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.57447
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15417191', '14668022', '14285007', '14975605', '14038915']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082465213546017
- 35 USC 102 Novelty (BERT): 0.6021724296101744
- Combined Prediction Score: 0.7876391121801589
- Mean Citation Score: 464.299616
- Max Citation Score: 613.6288
- Similarity Product: 431.3384419368744

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test